IOBT Q2 2024 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$214,000

Operating Income

-$22M

Net Income

-$21M

EPS (Diluted)

$-0.31

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$111M

Total Liabilities

$15M

Stockholders' Equity

$96M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$214,000	-$187,000	-14.4%
Operating Income	-$22M	-$22M	+1.5%
Net Income	-$21M	-$21M	+2.3%